Day 1 | 4Th Session: Ageing With Progressive Ms By Xavier Montalban

Day 1 | 4th Session: Ageing with Progressive MS by Xavier Montalban

5th Annual Congress of SLCTRIMS (2024) - Day 1 - Session 1

Prof. Xavier Montalban on the Revised McDonald Criteria: A New Era in MS Diagnosis & Management

ECTRIMS Congress

5th Annual Congress of SLCTRIMS (2024) - Day 1 - Session 3

Neuroregenerative agents in progressive multiple sclerosis

What is MS and will it get worse?

Day 1 | 2nd Session: Highlights on Research in Progressive MS by Mar Tintoré

Future areas of improvement in treating MS

Future directions for progressive multiple sclerosis

Annual Report 2015: new drug to reduce progression of primary progressive multiple sclerosis

Vall d'Hebron Barcelona Hospital Campus

Addressing unanswered questions in MS at AAN 2022

Advancing Multiple Sclerosis Diagnosis With the 2024 Criteria Revision

Xavier Montalban, EAN 2019 – Phase II study of first oral BTK inhibitor in multiple sclerosis

Touch Medical Media

Differential efficacy of DMTs in patients with active and inactive MS

Better understanding MS disease progression and monitoring